XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.3

Stock-based Compensation and Other Stock Plans (Tables)

9 Months Ended

Sep. 27, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model

The following weighted-average assumptions were used in calculating the fair value of stock options granted during the nine month periods ended September 27, 2025, and September 28, 2024, using the Black-Scholes valuation model:

									Nine Months Ended
															September 27, 2025						September 28, 2024
Expected term of stock option (in years)															4.57						4.90
Expected volatility factor															23.86%						23.63%
Expected dividend yield															2.52%						2.76%
Risk-free interest rate															4.36%						4.30%

Schedule of Stock Option Activity

Below is a summary of stock option activity as of and for the nine months ended September 27, 2025:

			Shares (in thousands)						Exercise Price Per Share*						Remaining Contractual Term* (in years)						Aggregate Intrinsic Value (in millions)
Outstanding at December 28, 2024			1,670						$	190.73
Granted			202						339.73
Exercised			(243)						168.61
Forfeited or expired			(18)						282.28
Outstanding at September 27, 2025			1,611						211.71						5.3						$	209.7
Exercisable at September 27, 2025			1,209						182.24						4.1						193.1

* Weighted-average

Schedule of Changes in Non-Vested Performance Awards

Changes to the company’s non-vested PSUs during the nine months ended September 27, 2025, are as follows:

			Shares (in thousands)						Fair Value Price per Share*
Non-vested PSUs at December 28, 2024			113						$	257.95
Granted			41						339.73
Performance assumption change **			(26)						254.75
Vested			—						—
Cancellations and other			(1)						278.22
Non-vested PSUs at September 27, 2025			127						285.12

*			Weighted-average
**			Reflects the number of PSUs adjusted based on performance metrics.

Schedule of Non-vested Restricted Stock Units Activity

Changes to the company’s non-vested RSUs during the nine months ended September 27, 2025, are as follows:

			Shares (in thousands)						Fair Value Price per Share*
Non-vested RSUs at December 28, 2024			70						$	242.63
Granted			18						339.73
Vested			(24)						212.27
Cancellations and other			(1)						280.38
Non-vested RSUs at September 27, 2025			63						282.05

* Weighted-average

Schedule of Weighted-Average Assumptions of Fair Value Granted Using Black-Scholes Valuation Model

The following weighted-average assumptions were used in calculating the fair value of stock-settled SARs granted during the nine month periods ended September 27, 2025, and September 28, 2024, using the Black-Scholes valuation model:

			Nine Months Ended
			September 27, 2025						September 28, 2024
Expected term of stock-settled SARs (in years)			4.11						4.20
Expected volatility factor			23.79%						23.80%
Expected dividend yield			2.52%						2.77%
Risk-free interest rate			4.39%						4.22%

The following weighted-average assumptions were used in calculating the fair value of cash-settled SARs granted during the nine month periods ended September 27, 2025, and September 28, 2024, using the Black-Scholes valuation model:

			Nine Months Ended
			September 27, 2025						September 28, 2024
Expected term of cash-settled SARs (in years)			3.54						3.65
Expected volatility factor			24.88%						23.53%
Expected dividend yield			2.50%						2.58%
Risk-free interest rate			3.66%						3.49%

Schedule of Changes in SARs

Below is a summary of stock-settled SARs as of and for the nine months ended September 27, 2025:

			Stock-settled SARs (in thousands)						Exercise Price Per Share*						Remaining Contractual Term* (in years)						Aggregate Intrinsic Value (in millions)
Outstanding at December 28, 2024			311						$	207.64
Granted			60						339.73
Exercised			(14)						179.18
Forfeited or expired			(30)						232.64
Outstanding at September 27, 2025			327						230.97						6.3						$	36.3
Exercisable at September 27, 2025			215						194.32						5.0						31.7

* Weighted-average

Changes to the company’s non-vested cash-settled SARs during the nine months ended September 27, 2025, are as follows:

			Cash-settled SARs (in thousands)						Fair Value Price per Share*
Non-vested cash-settled SARs at December 28, 2024			2						$	108.41
Granted			1						64.03
Vested			(1)						107.28
Non-vested cash-settled SARs at September 27, 2025			2						79.36

* Weighted-average

X

- Definition

Share-based compensation arrangement by share-based payment award, fair value assumptions.

+ References

No definition available.

+ Details

Name:	sna_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTableTextBlock
Namespace Prefix:	sna_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested performance-based units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration